Futures Rebound After Three Day Rout As Rates Ease From 2007 High US equity futures rebounded from a furious three-day selloff at the end...
Mark Velleca → David M. Epstein is out as CEO of cancer player Black Diamond Therapeutics, which is putting chairman Mark Velleca in charge. This is...
Key Points Consumer staples (NYMARKET:XLP) stocks are down 6.5% from their July highs and more than 10% from the 2022 ... Read more
Bond Bloodbath Trounces Tech; Batters Bitcoin, Banks, & Bullion A central bank smorgasbord started the day off with a bang of confusing...
We can no longer rely on central banks to prop up our investments, which means learning to look at the health of the companies and products...
Penny stocks to watch this week. The post Best Penny Stocks To Buy Now? 3 To Watch This Week appeared first on Penny Stocks to Buy,...
Futures, Global Stocks Tumble As Markets Reel After Fed's Hawkish Pause Futures are sharply lower, extending yesterday's steep losses after...
Retail stocks to watch right now. The post Top Stocks To Buy Now? 3 Retail Stocks For Your Watchlist appeared first on Stock Market News, Quotes,...
Binance reportedly said that they were doing a wallet aggregation process to ensure the safety of user funds. A crypto wallet belonging...
We are so excited that StockCharts.com is now offering you our ACP plugins, we had to write about it for today's Daily, especially since you can...
Stocks & Bonds Slammed As Powell Pi$$es In Next Year's Punchbowl If you're not confused now, you weren't paying attention. Fed held...
Last week, I introduced the SPDR Russell 1000 Low Volatility Focus ETF (NYSE: ONEV), a multi-factor smart beta fund that focused largely on low volatility...
Dealers "Stuffed On Gamma" Ahead Of Fed As The 'Sell The Prem, Live The Dream' Dynamic Continues (For Now) "Vol is aloof again," notes Nomura's...
Futures Rise, Dollar And Yields Slide Ahead Of Fed Decision US equity futures rose, alongside European markets, as traders awaited the Fed's...
Chanpeng Zhao, the CEO of Binance, said that the loan was the other way around, claiming that he was the one who lent $250 million to...
Can you name America’s oil king? It’s Texas, of course. Roughnecks pull 4X more “black gold” out of the ground ... Read more
Five top reasons to buy stocks are validated frequently in my work life. I use those five top reasons to buy stocks about once a month...
Quantum computing stocks to check out in the stock market right now. The post 2 Quantum Computing Stocks To Watch For Your Mid-September 2023 List appeared...
While the UAW strike continues, and the debate on how much it matters in the scheme of things rages on, other wage trends are emerging.Amazon (AZMN)...
Elutia Inc (NASDAQ: ELUT) shares bolstered a whopping 33% today as the company recently shared that they’ve secured about $10.5 million in funding through...
After years of rumors of an imminent IPO, Instacart has finally filed for a public offering of it’s shares, aspiring to raise about $600 million from...
Logica Capital commentary for the month ended August 31, 2023. Summary Equity markets stumbled a tad in August, and VIX/Implied ... Read more
S&P 500 made a dead cat bounce mixed with an intraday short squeeze, and given likely rise in yields (10y ... Read more
With recent buoyancy in the cannabis stocks, as reflected in AdvisorShares Pure US Cannabis ETF (NYSE: MSOS), the excitement surrounding future price...
The Appeal of Penny Stocks: Are Inexpensive Shares Under $1 a Good… The post 3 Penny Stocks To Buy For Under $1, Are They Worth The...
Second Injunction Issued Against CosMx PLEASANTON, Calif., Sept. 19, 2023 /PRNewswire/ -- 10x Genomics, Inc. (NASDAQ:TXG), a leader in single cell and...
Sick Thoughts Of Capitulating Submitted by QTR's Fringe Finance Almost daily, where I reside in Philadelphia, I jog or walk past the United...
Avinger Inc. (NASDAQ:AVGR) launched its Tigereye ST next generation image-guided chronic total occlusion (CTO) crossing system. The post Avinger stock...
Futures Flat As Traders Brace For Central Bank Deluge, Watch Surging Oil US futures were modestly in the green, reversing an earlier drop...
Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase...